Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MyreExpressen Kolding ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 7.8%   Bankruptcy risk   12.7% 14.2% 6.0% 7.0% 10.1% 6.1% 16.1% 12.5%   Credit score (0-100)   20 16 38 33 23 37 12 19   Credit rating   BB BB BBB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   428 711 1,879 2,444 3,132 3,160 0.0 0.0   EBITDA   -44.8 -271 415 185 -83.6 92.9 0.0 0.0   EBIT   -44.8 -287 368 101 -170 9.4 0.0 0.0   Pre-tax profit (PTP)   -46.9 -293.4 354.3 86.1 -183.2 1.4 0.0 0.0   Net earnings   -37.9 -230.7 275.2 64.3 -145.5 -3.6 0.0 0.0   Pre-tax profit without non-rec. items   -46.9 -293 354 86.1 -183 1.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 90.7 119 117 78.1 61.4 0.0 0.0   Shareholders equity total   12.1 -219 56.6 121 -24.6 222 159 159   Interest-bearing liabilities   5.6 288 169 127 83.5 37.2 0.0 0.0   Balance sheet total (assets)   147 232 1,180 868 658 806 159 159   Net Debt   1.2 284 -155 -95.4 -34.2 -128 -83.6 -83.6     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   428 711 1,879 2,444 3,132 3,160 0.0 0.0   Gross profit growth   0.0% 66.1% 164.1% 30.0% 28.2% 0.9% -100.0% 0.0%   Employees   1 3 4 5 8 7 0 0   Employee growth %   0.0% 200.0% 33.3% 25.0% 60.0% -12.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   147 232 1,180 868 658 806 159 159   Balance sheet change%   0.0% 57.7% 409.2% -26.5% -24.2% 22.6% -80.2% 0.0%   Added value   -44.8 -270.7 414.8 184.8 -86.0 92.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 74 202 -135 -173 -148 -61 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -10.5% -40.4% 19.6% 4.1% -5.4% 0.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -30.5% -96.2% 45.3% 9.8% -22.0% 1.5% 0.0% 0.0%   ROI %   -253.1% -188.2% 125.9% 36.2% -100.1% 6.5% 0.0% 0.0%   ROE %   -314.7% -189.2% 190.9% 72.5% -37.4% -0.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   8.2% -48.5% 4.8% 13.9% -3.6% 27.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2.8% -105.0% -37.5% -51.6% 40.9% -138.3% 0.0% 0.0%   Gearing %   46.8% -131.5% 297.9% 105.0% -339.9% 16.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   76.0% 4.2% 6.7% 9.8% 12.3% 16.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.4 0.9 0.9 0.7 0.8 0.0 0.0   Current Ratio   1.1 0.4 0.9 0.9 0.7 1.1 0.0 0.0   Cash and cash equivalent   4.4 3.4 324.0 222.3 117.7 165.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   12.1 -231.7 -87.8 -79.7 -190.9 84.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -45 -90 104 37 -11 13 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -45 -90 104 37 -10 13 0 0   EBIT / employee   -45 -96 92 20 -21 1 0 0   Net earnings / employee   -38 -77 69 13 -18 -1 0 0